Paper9815840
Optimal sampling strategies for bayesian estimation of docetaxel (Taxotere) clearance.
Baille P and 6 others. Clin Cancer Res, 1997. Cited by 47 papers, by iCite.
Cite this record
ConductScience Library. Optimal sampling strategies for bayesian estimation of docetaxel (Taxotere) clearance. Papers, record 9815840. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9815840
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents, Phytogenic | Major topic |
| Bayes Theorem | Major topic |
| Paclitaxel | Major topic |
| Sampling Studies | Major topic |
| Taxoids | Major topic |
| Antineoplastic Combined Chemotherapy Protocols | |
| Carcinoma, Non-Small-Cell Lung | |
| Cisplatin | |
| Docetaxel | |
| Humans | |
| Infusions, Intravenous | |
| Likelihood Functions | |
| Lung Neoplasms | |
| Metabolic Clearance Rate | |
| Neoplasms | |
| Prospective Studies | |
| Specimen Handling |
Source PubMed
Cited by13
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 47 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38734836 | Using maximum plasma concentration (Cmax) to personalize taxane treatment and reduce toxicity. | Cancer Chemother Pharmacol | 2024 | https://conductscience.org/library/papers/38734836 | PubMed |
| 32309383 | Clinical pharmacokinetics and drug exposure-toxicity correlation study of docetaxel based chemotherapy in Chinese head and neck cancer patients. | Ann Transl Med | 2020 | https://conductscience.org/library/papers/32309383 | PubMed |
| 21692829 | Effect of grapefruit juice on the pharmacokinetics of docetaxel in cancer patients: a case report. | Br J Clin Pharmacol | 2011 | https://conductscience.org/library/papers/21692829 | PubMed |
| 20628376 | Effect of ABCB1 C3435T polymorphism on docetaxel pharmacokinetics according to menopausal status in breast cancer patients. | Br J Cancer | 2010 | https://conductscience.org/library/papers/20628376 | PubMed |
| 18611060 | Population pharmacokinetics and pharmacodynamics for treatment optimization in clinical oncology. | Clin Pharmacokinet | 2008 | https://conductscience.org/library/papers/18611060 | PubMed |
| 17595656 | Clinical pharmacodynamic factors in docetaxel toxicity. | Br J Cancer | 2007 | https://conductscience.org/library/papers/17595656 | PubMed |
| 17518507 | A systematic review of limited sampling strategies for platinum agents used in cancer chemotherapy. | Clin Pharmacokinet | 2007 | https://conductscience.org/library/papers/17518507 | PubMed |
| 14678339 | Population pharmacokinetics of weekly docetaxel in patients with advanced cancer. | Br J Clin Pharmacol | 2004 | https://conductscience.org/library/papers/14678339 | PubMed |
| 12889741 | Pharmacokinetic-pharmacodynamic guided trial design in oncology. | Invest New Drugs | 2003 | https://conductscience.org/library/papers/12889741 | PubMed |
| 12445024 | Development and validation of limited sampling strategies for prediction of the systemic exposure to the novel anticancer agent E7070 (N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide). | Br J Clin Pharmacol | 2002 | https://conductscience.org/library/papers/12445024 | PubMed |
| 11392450 | Population pharmacokinetics and pharmacokinetic-pharmacodynamic relationships for docetaxel. | Invest New Drugs | 2001 | https://conductscience.org/library/papers/11392450 | PubMed |
| 10803455 | Adaptive control methods for the dose individualisation of anticancer agents. | Clin Pharmacokinet | 2000 | https://conductscience.org/library/papers/10803455 | PubMed |
| 10233199 | A pharmacokinetic model for alpha interferon administered subcutaneously. | Br J Clin Pharmacol | 1999 | https://conductscience.org/library/papers/10233199 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9815840
GET https://conductscience.org/api/papers/v1/9815840/authors